甘草次酸修饰海藻酸钠纳米给药系统的肝靶向性评估

通过EDC/NHS偶联反应将疏水性肝靶向小分子甘草次酸(GA)连接到天然多糖海藻酸钠(ALG)上,制备了具有双亲性肝靶向药物载体材料(GA-ALG).采用乳化法对广谱抗癌药物阿霉素(DOX)进行包载,得到肝靶向载药纳米粒子( DOX/GA-ALG NPs).利用单光子发射型计算机断层成像技术(SPECT)和药物体内分布...     

基于海藻酸钠衍生物的肝靶向纳米前药的构建及抗肿瘤活性研究

利用寡聚乙二醇(mOEG)修饰海藻酸钠(ALG), 有效降低了ALG的黏度, 提高了其对疏水性肝靶向配体甘草次酸(GA)的负载量. 结果表明, 靶向材料(GA-ALG-mOEG)的GA负载量为11.8%, 是对照组(GA-ALG)的1.97倍. 在此基础上, 以物理交联的方式引入pH响应的阿霉素前药(DOX-ALG-mOEG), 制备了肝靶向纳米前药(DOX-ALG-mOEG/GA-ALG-mOEG NPs). 细胞实验及抑瘤实验结果表明, 该前药较对照组(DOX-ALG/GA-ALG NPs)具有更高的肝靶向性和药物利用率, 其对肝癌细胞的半致死率浓度(IC₅₀)为58.1 ng/mL, 是对照组(IC₅₀=141.7 ng/mL)的41%; 动物实验结果显示, 该前药的抑瘤率达到了88.4%, 比对照组提高了11.5%.     

可生物降解固体脂质纳米粒的制备、表征及药物的体外释放

以可生物降解材料硬脂酸为载体, 以葛根总黄酮为模型药物, 采用乳化蒸发-低温固化法制备固体脂质纳米粒. 采用透射电镜研究载药纳米粒形态, 激光粒度分析仪测定其粒径, X射线衍射仪进行物相鉴别, 并对纳米粒的包封率及体外释药特性等进行了研究. 分析结果表明, 所制备硬脂酸固态脂质纳米粒为类球实体, 粒径分布比较均匀, 平均粒径为(263.82±3.6) nm, 包封率为(67.53±0.12)%. X射线衍射分析证明药物以分子或细小粒子分散于脂质骨架中. 体外释药研究结果表明, 纳米粒体外释药先快后慢, 12 h累积释药50%, 包封于降解材料骨架内的药物通过骨架溶蚀缓慢释放. 药物的体外释放符合Higuchi方程.     

叶酸靶向乙酰普鲁兰纳米粒的制备及其靶向作用

以普鲁兰多糖为主链, 通过乙酰化反应合成了疏水性的乙酰普鲁兰(PA), 然后以N,N′-二环己基碳二亚胺(DCC)为偶联剂, 4-二甲氨基吡啶(DMAP)为催化剂, 将叶酸与PA偶联(FPA); 采用¹H NMR和X射线晶体衍射(XRD)等方法对产物结构进行了表征. 采用溶剂扩散法制备包载表阿霉素的PA和FPA纳米粒, 载药纳米粒形态为球形, 动态光散射粒径分析显示载药纳米粒粒径随载药量增加而增大. 透析法测定纳米粒中表阿霉素的体外释放表明, FPA纳米粒中药物释放速度快于PA纳米粒; 采用激光共聚焦显微镜观察PA/EPI及FPA/EPI纳米粒在KB细胞的摄取情况, 结果表明, FPA/EPI纳米粒进入细胞主要通过叶酸受体途径, 而PA/EPI纳米粒进入细胞与叶酸受体无关, 提示FPA将成为具有一定肿瘤靶向作用的新型载体.     

改良自乳化溶剂挥发法制备MePEG-PLGA纳米粒的研究

对改良自乳化溶剂挥发法制备甲氧基封端的聚乙二阵-聚乳酸聚乙醇酸嵌段聚合物（MePEG—PL—GA）纳米粒的工艺进行优化,并对纳米粒子加以表征。以形态、粒径为指标,采用正交设计筛选出比较理想的制备工艺。以扫描电镜（SEM）和动态光散射粒度分析仪（DLS）对纳米粒的形态、大小和zeta电位进行研究。优化的制备方案：丙酮与乙醇体积比为3：3,MePEG—PLGA 30mg,聚乙烯醇（PVA）含量为3％,有机相与水相体积比为1：10。所得纳米粒为球形粒子,分布较均匀,平均粒径118．9nm。zeta电位为-1．7mV。改良自乳化溶剂挥发法适于MePEG—PLGA纳米粒子的制备。     

基于天然高分子基元的阻隔层对磁性载药聚乳酸微球的控释作用

利用层层组装技术构建了基于天然高分子壳聚糖和海藻酸钠的阻隔层, 并研究了该阻隔层对磁性载药聚乳酸微球的药物释放作用. 实验结果表明, 阻隔层能够有效抑制模型药物的突释, 具有延缓药物释放的效果. 具有阻隔层的磁性载药体系具有药物释放平缓和生物相容性高等特点, 是理想的磁靶向载药体系.     

海藻酸钠前药纳米粒在肿瘤光动力治疗中的应用研究

利用具有还原敏感性的胱胺将疏水性光敏剂脱镁叶绿酸盐A(Pheo A)偶联到天然多糖海藻酸钠(ALG)上,得到同时具有光敏性和还原敏感性的两亲性多糖前药(Pheo A-ALG),再通过疏水相互作用自组装形成前药纳米粒(Pheo A-ALG NPs),应用于肿瘤光动力治疗.对Pheo A-ALG NPs的理化性质进行了评价,体外考察Pheo A-ALG NPs的释药行为、细胞胞吞及胞内ROS,并重点研究了Pheo A-ALG NPs的体外细胞毒性以及体内抑瘤活性.     

应用于药物传输系统的聚合物纳米粒

载药聚合物纳米粒具有良好的组织靶向性和缓控释性，本文简要介绍了聚合物纳米粒在药物传输系统中的特点，综合分析并讨论了纳米粒的制备技术及应用，展望了今后的研究方向。     

多功能磁性纳米粒的合成、修饰及生物医学应用

多功能磁性纳米粒由于其独特的性质而受到广泛的关注。磁性纳米粒可以与荧光探针、生物靶向分子或抗肿瘤药物等相结合实现磁性纳米粒的多功能化,因此在多模式成像、癌症的靶向诊断与治疗中有较好的应用前景。本文介绍了磁性纳米粒的合成以及多功能磁性纳米粒的构建方法,重点介绍了核壳型、哑铃型和组合杂化型三种不同类型多功能磁性纳米粒的合成方法。多功能磁性纳米粒通常具有粒径小、超顺磁性以及荧光等独特性质,在此基础上对纳米粒表面进行稳定化和靶向性修饰后即可在多模式成像、特异性靶向药物输送、基因转染等生物医学领域得到应用。最后指出了当前研究中需要解决的问题。     

聚合物纳米粒应用于透皮给药及促渗机制研究进展

透皮给药系统因具有避免肝脏首过效应、血药浓度稳定、局部靶向性及给药方便等优势而备受青睐。然而角质层作为一种生物屏障限制了很多药物,特别是亲水性药物的经皮渗透,因此采用有效的方法促进药物经皮渗透成为透皮给药的关键。聚合物纳米粒因具有药物包封率高、减小酶降解、可控释性能好、比表面积大等优势,易于在皮肤表面富集,从而促进药物渗透,其作为药物载体用于透皮给药逐渐成为近几年的研究热点。本文综述了近年来纳米粒在促进药物渗透方面的研究进展,包括纳米粒促进药物渗透的机制,以及纳米粒联合主动透皮给药方式在促进药物经皮渗透中的应用,并对研究中存在的问题提出适当建议。     

Cytotoxicity of liver targeted drug-loaded alginate nanoparticles

In this study, novel liver targeted doxorubicin (DOX) loaded alginate (ALG) nanoparticles were prepared by CaCl₂ crosslinking method. Glycyrrhetinic acid (GA, a liver targeted molecule) modified alginate (GA-ALG) was synthesized in a heterogeneous system, and the structure of GA-ALG and the substitution degree of GA were analyzed by ¹H NMR, FT-IR and elemental analysis. The drug release profile under the simulated physiological condition and cytotoxicity experiments of drug-loaded GA-ALG nanoparticles were carried out in vitro. Transmission electron micrographs (TEM) and dynamic light scattering (DLS) analysis showed that drug-loaded GA-ALG nanoparticles have spherical shape structure with the mean hydrodynamic diameter around 214 ± 11 nm. The drug release was shown to last 20 days, and the MTT assay suggested that drug-loaded GA-ALG nanoparticles had a distinct killing effect on 7703 hepatocellular carcinoma cells.     

Studies on antineoplastic effect by adjusting ratios of targeted-ligand and antitumor drug

A series of drug delivery systems based on a sodium alginate derivative were prepared by mixing glycyrrhetinic acid(GA) and doxorubicin(DOX) conjugates at different ratios. GA(a liver-targeting ligand) and DOX(an antitumor drug) were both conjugated to oligomeric glycol monomethyl ether-modified sodium alginate(ALG-mOEG) for prolonged duration of action. These NP-based delivery systems exhibited active cell uptake and cytotoxicity in vitro and liver-targeted distribution and anti-tumor activity in vivo. In addition, nanoparticles with a 1:1(W:W) ratio of GA-ALG-mOEG and DOXALG-mOEG(NPs-3) showed the highest cellular uptake and cytotoxicity in vitro and liver-targeted distribution and antitumor activity in vivo. Specifically, when mixed nanoparticles defined as NPs-3 were injected in mice, liver DOX concentration reached 61.9 μg/g 3 h after injection, and AUC0-∞ and t1/2 of DOX in liver reached 4744.9 μg·h/g and 49.5 h, respectively. In addition, mice receiving a single injection of NPs-3 exhibited much slower tumor growth(88.37% reduction in tumor weight) 16 days after injection compared with placebo. These results indicate that effective cancer treatment may be developed using mixed NP delivery systems with appropriate ratio of targeted ligand and drug.     

海藻酸-壳聚糖-海藻酸离子取代凝胶改性研究

羧甲基壳聚糖;微胶囊;海藻酸-壳聚糖-海藻酸离子取代凝胶改性研究     

Synthesis of aligned hematite nanoparticles on chitosan–alginate films

Iron oxide nanoparticles are being viewed with interest owing to the great potential they have in the biomedical applications like MRI contrast enhancement, targeted drug delivery, hyperthermia and recently in magnetic separation of cancer cells from the body. Templated synthesis has been considered ideal for synthesis of iron oxide nanoparticles as particles are attracted magnetically, in addition to usual flocculation through van der Waals attraction. Biological templates are attractive owing to their biocompatibility and the attractive porosity and surface chemistry that nature provides. Polysaccharides like chitosan and alginate have been employed in the synthesis of a polyion complex, which provided the active-binding sites for iron(II) ions in solution to bind. The natural organization of chitosan and alginate into a porous film has been exploited to synthesize spherical iron oxide nanoparticles through careful calcination of the iron(II) conjugate film. Our experiments indicate that the formed nanoparticles are highly crystalline, confirm to the hematite structure and have a superparamagnetic response with a low coercivity of 116 Oe. Particles thus synthesized were highly monodisperse with hydrodynamic diameter of 1.8 nm. The symmetric porosity of the film translates into the synthesis of well-aligned nanoparticles of iron oxide. Compared to synthesis in solution, the film-assisted synthesis offered a greater degree of control over the particle size distribution pattern, with the chitosan–alginate template providing the needed spatial separation to prevent the aggregation due to magnetostatic coupling. Such hematite nanoparticles can either be used directly or converted to paramagnetic magnetite by reduction. Zeta potential measurements indicate highly stable nanoparticles, which can therefore be conjugated to cationic liposomes carrying drugs and magnetically guided to target sites.     

热磁双重响应性载药微囊的制备及其性能研究

采用LbL模板技术,将天然聚电解质壳聚糖CS和海藻酸钠ALG、磁性纳米颗粒Fe3O4或带负电荷或双亲性磷脂在单分散胶体表面进行组装,制备了一种具有热磁双重响应性的新型载药微囊.通过透射电镜、激光共聚焦显微镜、zeta-电位分析仪、紫外分光光度计等对微囊结构及载药、释药性能进行了表征.实验结果表明:微囊的载药量最高可达到22.40%,且具有磁导向作用.微囊外层组装具有热敏性质的磷脂层能有效地克服壳聚糖/海藻酸钠微囊通透性大而导致在较低温(正常生理环境)的输送过程中药物泄漏问题,而在较高温条件下又可使药物迅速释放,从而实现药物的可控释放.     

肝靶向甘草次酸修饰的壳聚糖纳米粒子的合成和表征

合成了修饰甘草次酸的壳聚糖(GA-CTS), 采用离子交联法制备了GA-CTS纳米粒子. 该材料可能具有肝细胞主动靶向作用, 为进一步的肝靶向药物控释的研究奠定了基础.     

Calcium-Alginate Nanoparticles Formed by Reverse Microemulsion as Gene Carriers

Natural biopolymers are widely used in the field of drug and gene delivery. In this study, alginate nanoparticles were prepared using water-in-oil microemulsion as a template followed by calcium crosslinking of guluronic acid units of alginate polymer. After collected by ultracentrifugation, alginate nanoparticles were analyzed by electron microscopy to obtain the size and morphology which were varied with the ratio of water, oil, and surfactant used. To examine the potency of Ca-alginate nanoparticles as carriers for gene delivery, GFP-encoding plasmids were encapsulated in these nanoparticles to investigate the degree of endocytosis by NIH 3T3 cells and ensuing transfection rate. Our results showed that Ca-alginate nanoparticles with an average size around 80 nm in diameter are very efficient gene carriers, in comparison with plasmid DNA condensed by polyethyleneimine (PEI).     

Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers

This study focused on evaluating four emulsion-based processing strategies for polymeric nanoparticle synthesis to explicate the mechanisms of nanoparticle formation and the influence on achieving sustained-release of two anti-tuberculosis drugs, isoniazid and rifampicin. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles were formulated with and without sorbitan mono-oleate as a stabilizer using emulsion-solvent-surfactant-evaporation (ESSE) and emulsion-solvent-evaporation (ESE) approaches. An alginate solution gelled by ionic crosslinking with calcium chloride was employed to prepare alginate hydrogel nanoparticles via reverse-emulsion-cationic-gelification (RECG) and reverse-emulsion-surfactant-cationic-gelification (RESCG) approaches. In vitro drug release analysis was performed. The size, zeta potential and morphology of the nanoparticles were analyzed. Molecular mechanics energy relationships (MMER) were employed to explore the spatial disposition of alginate and PLGA with respect to the emulsifying profile of sorbitan monooleate and to corroborate the experimental findings. Results revealed that particle size of the PLGA nanoparticles was influenced by the stabilizer concentration. Nanoparticles synthesized by the ESSE approach had smaller sizes of 240±8.7 nm and 195.5±5.4 nm for rifampicin- and isoniazid-loaded nanoparticles, respectively. This was a substantial size reduction from nanoparticles generated by the ESE approach (>1000 nm). The RESCG approach produced stable and higher nanoparticle yields with desirable size (277±1.0 nm; 289±1.2 nm), a low polydispersity index (27.1±0.3 mV; 28.5±0.5 mV) and drug entrapment efficiency of 73% and 75% for isoniazid and rifampicin, respectively. Drug release from the ESSE and RESCG synthesized nanoparticles displayed desirable release of the two anti-TB drugs with sustained zero-order kinetics over a period of 8h. MMER supported the mechanisms of nanoparticle formation with a sphericalized interlaced network configuration.